Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1961
|
| gptkbp:ATCCode |
N06AA09
|
| gptkbp:availableOn |
gptkb:government_agency
gptkb:tablet |
| gptkbp:brand |
gptkb:amitriptyline
|
| gptkbp:CASNumber |
50-48-6
|
| gptkbp:chemicalFormula |
C20H23N
|
| gptkbp:contraindication |
recent myocardial infarction
concurrent MAOI use |
| gptkbp:drugClass |
antidepressant
|
| gptkbp:eliminationHalfLife |
10-50 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Elavil
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
constipation
blurred vision weight gain drowsiness dry mouth urinary retention |
| gptkbp:usedFor |
gptkb:depression
peripheral neuropathy anxiety disorders fibromyalgia migraine prevention |
| gptkbp:bfsParent |
gptkb:amitriptyline
|
| gptkbp:bfsLayer |
6
|